Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Oct 13, 2026

NVNO — enVVeno Medical Corporation Dilution Risk Tracker

Track NVNO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NVNO — Get alerts when the score changes →

As of October 13, 2026, enVVeno Medical Corporation (NVNO) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. enVVeno Medical Corporation has a market capitalization of $5.56M, 682.7K shares outstanding, 1 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
42
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 30%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 44% potential dilution
• Convertible risk score very high (85/100)
🔔 Track NVNO — Get forecast alerts →

Market Data

Market Cap$5.56M
Shares Outstanding682.7K
Float486.1K
Cash$21.49M
Debt$603.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore56/100DilutionWatch score record
Shares Outstanding682.7KVerified float table or market cache
Public Float486.1KVerified float table or market cache
Market Cap$5.56MMarket data cache
Cash Runway16.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 3.

Recent SEC source mix: 4 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 99.9% shares (2026Q1 vs prior)
1 institutional holders · 6.6K shares
#1 MORGAN STANLEY 6.6K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.5K
Days to Cover1.0
% of Float2.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-30
xbrl XBRL CONVERTIBLE 2020-03-18
4 INSIDER TRANSACTION 2026-03-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NVNO Dilution Snapshot

enVVeno Medical Corporation (NVNO) has a DilutionScore of 56/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NVNO's DilutionScore is currently 56/100 (High risk), with 5 score changes tracked over 89 days. The score improved from 55/100 (High risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202656/100HIGH6 days
Oct 01 – Oct 07, 202655/100HIGH7 days
Sep 14 – Sep 30, 202663/100HIGH17 days
Aug 22 – Sep 13, 202664/100HIGH23 days
Aug 14 – Aug 21, 202643/100MEDIUM7 days
Jul 16 – Aug 13, 202655/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NVNO shares outstanding have increased 1.9% from 655.0K (Apr 2026) to 667.7K (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 2026667.7K486.1K▲ 0.70%
May 18, 2026667.7K482.7K▲ 1.85%
Apr 01, 2026655.0K473.9K▲ 13.52%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NVNO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NVNO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NVNO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NVNO
NVNO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.